NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis

Nour Ershaid(Tel Aviv University), Yoray Sharon(Tel Aviv University), Hila Doron(Tel Aviv University), Yael Raz(Tel Aviv University), Ophir Shani(Tel Aviv University), Noam Cohen(Tel Aviv University), Lea Monteran(Tel Aviv University), Leonor Leider–Trejo(Tel Aviv University), Amir Ben‐Shmuel(Israel Institute for Biological Research), Muhammad Yassin(Tel Aviv University), Motti Gerlic(Tel Aviv University), Adit Ben‐Baruch(Tel Aviv University), Metsada Pasmanik‐Chor(Tel Aviv University), Roni Apte(Ben-Gurion University of the Negev), Neta Erez(Tel Aviv University)
Nature Communications
September 26, 2019
Cited by 309Open Access
Full Text

Abstract

Cancer-Associated Fibroblasts (CAFs) were shown to orchestrate tumour-promoting inflammation in multiple malignancies, including breast cancer. However, the molecular pathways that govern the inflammatory role of CAFs are poorly characterised. In this study we found that fibroblasts sense damage-associated molecular patterns (DAMPs), and in response activate the NLRP3 inflammasome pathway, resulting in instigation of pro-inflammatory signalling and secretion of IL-1β. This upregulation was evident in CAFs in mouse and in human breast carcinomas. Moreover, CAF-derived inflammasome signalling facilitated tumour growth and metastasis, which was attenuated when NLRP3 or IL-1β were specifically ablated. Functionally, CAF-derived inflammasome promoted tumour progression and metastasis by modulating the tumour microenvironment towards an immune suppressive milieu and by upregulating the expression of adhesion molecules on endothelial cells. Our findings elucidate a mechanism by which CAFs promote breast cancer progression and metastasis, by linking the physiological tissue damage response of fibroblasts with tumour-promoting inflammation.


Related Papers

No related papers found

Powered by citation graph analysis